BIOMEDITECH ApS: Financial statements 2018
CVR: 34707847
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
BIOMEDITECH ApS (CVR 34707847) has filed annual accounts for 2018. In 2018, the company reported a net result of DKK -17,579 compared with DKK -28,108 the year before. Equity in the 2018 report amounted to DKK 47,349. The solvency ratio was 89.8%.
- Profit/Loss
- DKK -17,579
- Equity
- DKK 47,349
- Total Assets
- DKK 52,737
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | - | -18 t. | 47 t. | - |
| 2017 | - | - | -28 t. | 65 t. | - |
| 2016 | - | - | -31 t. | 93 t. | - |
| 2015 | 0 | 0 | 0 | 124 t. | - |
| 2014 | 0 | 0 | 35 | 124 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
BIOMEDITECH ApS has published its annual report for 2017. The net result was DKK -28,108.
About BIOMEDITECH ApS
BIOMEDITECH ApS is a Danish company of the type Anpartsselskab based in Herlev, founded in 2012. The company is registered under the industry Engroshandel med andre maskiner og andet udstyr. The company was previously named DRUG TESTING EUROPE ApS. The management consists of Tobias Chalmer Stahl Rasmussen. The company is owned by Chalmer Holding ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 106,895 and a net result of DKK -6,298 compared with DKK 290,046 the year before. Equity in the 2025 report amounted to DKK 877,884.